In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLC

IF 20.8 1区医学 Q1 ONCOLOGY

Journal of Thoracic Oncology Pub Date : 2025-07-01 DOI:10.1016/j.jtho.2025.03.035

Qian Yan MD, Jinlin Liu MD, PhD

引用次数: 0

查看原文本刊更多论文

原位检测程序性细胞死亡蛋白1和程序性死亡配体1相互作用作为非小细胞肺癌免疫检查点抑制反应的功能预测因子

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Thoracic Oncology 医学-呼吸系统

CiteScore

36.00

自引率

3.90%

发文量

1406

审稿时长

13 days

期刊介绍： Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.